M Hallek| - JoVE Visualize

Showing results (81-90 of 152) with videos related to

Pageof 16

Sort By:

Deutsche Medizinische Wochenschrift (1946)|March 21, 2013

[Morbidity and mortality conferences in internal medicine--experience at the University Hospital of Cologne]I Suárez, P Langerbeins, C Mattonet, et al.

Cellular Immunology|October 15, 1995

Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cellsC Pignata, K V Prasad, M Hallek, et al.

Gene Therapy|July 2, 2003

Receptor targeting of adeno-associated virus vectorsH Büning, M U Ried, L Perabo, et al.

Infectious Diseases in Obstetrics and Gynecology|August 7, 2008

Necrotizing pneumonia caused by Panton-Valentine leucocidin-producing Staphylococcus aureus originating from a Bartholin's abscessN Jung, C Lehmann, M Hellmann, et al.

Annals of Hematology|November 7, 1999

Eosinophilia during fludarabine treatment of chronic lymphocytic leukemiaO Sezer, P Schmid, M Hallek, et al.

Blood|June 1, 1992

Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinaseK Okuda, J S Sanghera, S L Pelech, et al.

Oncogene|February 22, 2007

Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinasesA Hausherr, R Tavares, M Schäffer, et al.

British Journal of Cancer|January 7, 2015

Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalisation without inducing empty basement membrane sleeves in xenograft tumoursO Coutelle, L M Schiffmann, M Liwschitz, et al.

Cancer Research|September 15, 1995

CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell lineC M Wendtner, B Schmitt, H J Gruss, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000

The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-XC Oetzel, T Jonuleit, A Götz, et al.

Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:

Pageof 16

Deutsche Medizinische Wochenschrift (1946)|March 21, 2013

[Morbidity and mortality conferences in internal medicine--experience at the University Hospital of Cologne]I Suárez, P Langerbeins, C Mattonet, et al.

Cellular Immunology|October 15, 1995

Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cellsC Pignata, K V Prasad, M Hallek, et al.

Gene Therapy|July 2, 2003

Receptor targeting of adeno-associated virus vectorsH Büning, M U Ried, L Perabo, et al.

Infectious Diseases in Obstetrics and Gynecology|August 7, 2008

Necrotizing pneumonia caused by Panton-Valentine leucocidin-producing Staphylococcus aureus originating from a Bartholin's abscessN Jung, C Lehmann, M Hellmann, et al.

Annals of Hematology|November 7, 1999

Eosinophilia during fludarabine treatment of chronic lymphocytic leukemiaO Sezer, P Schmid, M Hallek, et al.

Blood|June 1, 1992

Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinaseK Okuda, J S Sanghera, S L Pelech, et al.

Oncogene|February 22, 2007

Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinasesA Hausherr, R Tavares, M Schäffer, et al.

British Journal of Cancer|January 7, 2015

Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalisation without inducing empty basement membrane sleeves in xenograft tumoursO Coutelle, L M Schiffmann, M Liwschitz, et al.

Cancer Research|September 15, 1995

CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell lineC M Wendtner, B Schmitt, H J Gruss, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000

The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-XC Oetzel, T Jonuleit, A Götz, et al.

Pageof 16